StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research note released on Tuesday. The firm issued a sell rating on the stock.
Ampio Pharmaceuticals Stock Performance
AMPE opened at $0.00 on Tuesday. The firm has a market cap of $2,497.00, a PE ratio of 0.00 and a beta of 3.67. Ampio Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $7.47.
Ampio Pharmaceuticals Company Profile
Featured Articles
- Five stocks we like better than Ampio Pharmaceuticals
- How to Invest in Small Cap StocksĀ
- Texas Roadhouse Stock Steering for New Highs This Year
- What is the S&P/TSX Index?
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.